375 related articles for article (PubMed ID: 11058964)
21. An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter.
Macias MP; Stinski MF
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):707-11. PubMed ID: 8380646
[TBL] [Abstract][Full Text] [Related]
22. Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter.
Schwartz R; Sommer MH; Scully A; Spector DH
J Virol; 1994 Sep; 68(9):5613-22. PubMed ID: 8057441
[TBL] [Abstract][Full Text] [Related]
23. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
24. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB.
Lang D; Gebert S; Arlt H; Stamminger T
J Virol; 1995 Oct; 69(10):6030-7. PubMed ID: 7666507
[TBL] [Abstract][Full Text] [Related]
25. The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator.
Bogomolski-Yahalom V; Klein A; Greenblat I; Haviv Y; Tur-Kaspa R
Virus Res; 1997 May; 49(1):1-7. PubMed ID: 9178491
[TBL] [Abstract][Full Text] [Related]
26. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
27. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein.
Choi KS; Kim SJ; Kim S
Virology; 1995 Apr; 208(2):450-6. PubMed ID: 7747417
[TBL] [Abstract][Full Text] [Related]
28. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53.
Tsai HL; Kou GH; Chen SC; Wu CW; Lin YS
J Biol Chem; 1996 Feb; 271(7):3534-40. PubMed ID: 8631958
[TBL] [Abstract][Full Text] [Related]
29. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
Kim JM; Hong Y; Semba K; Kim S
Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
[TBL] [Abstract][Full Text] [Related]
30. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus.
Chiou CJ; Zong J; Waheed I; Hayward GS
J Virol; 1993 Oct; 67(10):6201-14. PubMed ID: 8396676
[TBL] [Abstract][Full Text] [Related]
31. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box.
Tatarowicz WA; Martin CE; Pekosz AS; Madden SL; Rauscher FJ; Chiang SY; Beerman TA; Fraser NW
J Neurovirol; 1997 Jun; 3(3):212-24. PubMed ID: 9200069
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression.
Caswell R; Bryant L; Sinclair J
J Virol; 1996 Jun; 70(6):4028-37. PubMed ID: 8648740
[TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain.
Jupp R; Hoffmann S; Stenberg RM; Nelson JA; Ghazal P
J Virol; 1993 Dec; 67(12):7539-46. PubMed ID: 8230473
[TBL] [Abstract][Full Text] [Related]
34. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
35. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
Liu X; Miller CW; Koeffler PH; Berk AJ
Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
[TBL] [Abstract][Full Text] [Related]
36. TAF-like functions of human cytomegalovirus immediate-early proteins.
Lukac DM; Harel NY; Tanese N; Alwine JC
J Virol; 1997 Oct; 71(10):7227-39. PubMed ID: 9311796
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of transcriptional activation and repression can both involve TFIID.
Manley JL; Um M; Li C; Ashali H
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
[TBL] [Abstract][Full Text] [Related]
38. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.
Wing BA; Johnson RA; Huang ES
J Virol; 1998 Mar; 72(3):1814-25. PubMed ID: 9499032
[TBL] [Abstract][Full Text] [Related]
39. Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.
Jupp R; Hoffmann S; Depto A; Stenberg RM; Ghazal P; Nelson JA
J Virol; 1993 Sep; 67(9):5595-604. PubMed ID: 8394462
[TBL] [Abstract][Full Text] [Related]
40. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.
Gu B; DeLuca N
J Virol; 1994 Dec; 68(12):7953-65. PubMed ID: 7966586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
